Related Experiment Video
Updated: Jul 13, 2026
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Published on: February 2, 2013
Direct detection of cytolytic T lymphocyte-mediated cytotoxicity on antigen-transfected cell microarray
Jianhui Rong1, R Chris Bleackley, Kevin P Kane
1Department of Medical Microbiology and Immunology, University of Alberta, 660 Heritage Medical Research Centre, Edmonton, AB, Canada T6G 2S2.
Abstract:
CD8(+) T lymphocytes are capable of recognizing and destroying cancer cells or virally infected cells and can thus offer protection from cellular malignant transformation and pathogenic challenges. With large numbers of genes discovered in genome analyses, rapid identification of cancer or viral antigens would facilitate better exploitation of CD8(+) T lymphocyte-mediated immune protection. Reverse transfection microarray technology allows expression of individual cDNAs at defined positions in a cell monolayer and direct detection of corresponding phenotypic changes of transfected cells at specific locations. In this study, we have integrated reverse transfection with image-based fluorometric detection of antigen-specific CTL-mediated cytotoxicity on transfected cell microarrays. As a result, the antigen recognition of cloned CTL cells has been successfully detected on the cell microarray, in which the specific or non-specific mini-gene DNA in the expression vector or vector alone was spotted. Moreover, the cellular capability of antigen processing and presentation on microarray has also been evaluated by using chimeric DNA constructs containing the antigen-encoding mini-gene sequence. This novel approach may facilitate high throughput screens of cancer cell or virus cDNA libraries to identify individual cDNAs that encode targets for immune intervention.
Insights
This study introduces a new method using transfected cell microarrays to detect how CD8(+) T lymphocytes recognize cancer and viral antigens. This approach aids in identifying targets for immune interventions against diseases.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- CD8(+) T lymphocytes are crucial for identifying and eliminating cancer cells and virally infected cells.
- Genome analyses yield numerous genes, necessitating efficient methods for identifying cancer or viral antigens to enhance immune protection.
- Current methods require improvement for rapid antigen identification to leverage CD8(+) T lymphocyte-mediated immunity.
Purpose of the Study:
- To develop and validate a novel high-throughput screening method for identifying cancer and viral antigens.
- To integrate reverse transfection microarray technology with fluorometric detection for analyzing antigen-specific CD8(+) T lymphocyte responses.
- To evaluate the cellular capacity for antigen processing and presentation within the microarray system.
Main Methods:
- Utilized reverse transfection microarray technology for localized cDNA expression in a cell monolayer.
- Integrated image-based fluorometric detection to monitor antigen-specific cytotoxic T lymphocyte (CTL) activity.
- Employed chimeric DNA constructs to assess antigen processing and presentation capabilities on the microarray.
Main Results:
- Successfully detected antigen recognition by cloned CTL cells on the cell microarray.
- Demonstrated the ability to identify specific antigen-encoding mini-genes within expression vectors.
- Evaluated cellular antigen processing and presentation using engineered DNA constructs on the microarray.
Conclusions:
- The developed reverse transfection microarray system enables the detection of antigen-specific CTL-mediated cytotoxicity.
- This novel approach facilitates high-throughput screening of cDNA libraries for identifying immune intervention targets.
- The technology holds promise for accelerating the discovery of antigens relevant to cancer and viral diseases.
